应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02359 药明康德
休市中 05-03 16:09:00
36.600
-2.050
-5.30%
最高
39.100
最低
35.800
成交量
664.11万
今开
38.600
昨收
38.650
日振幅
8.54%
总市值
1,074亿
流通市值
141.67亿
总股本
29.33亿
成交额
2.45亿
换手率
1.72%
流通股本
3.87亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
港股收盘(05.03) | 恒指收涨1.48% 科网股、博彩股再度强势 快狗打车(02246)盘中暴拉1.25倍
智通财经 · 05-03 16:39
港股收盘(05.03) | 恒指收涨1.48% 科网股、博彩股再度强势 快狗打车(02246)盘中暴拉1.25倍
港股药明系普跌
第一财经 · 05-03 15:50
港股药明系普跌
药明康德港股一度跌超7% 此前招商证券下调其港股评级至持有
新浪港股 · 05-03 15:48
药明康德港股一度跌超7% 此前招商证券下调其港股评级至持有
【券商聚焦】招银国际削药明康德(02359)A股目标价20.9% 惟指其首季业绩在艰难环境下表现平稳
金吾财讯 · 05-03 14:17
【券商聚焦】招银国际削药明康德(02359)A股目标价20.9% 惟指其首季业绩在艰难环境下表现平稳
港股异动 | CRO概念股全线回落 药明康德(02359)跌超7%领跌 公司首季利润率不及预期
智通财经 · 05-03 11:26
港股异动 | CRO概念股全线回落 药明康德(02359)跌超7%领跌 公司首季利润率不及预期
【港股通】药明康德(02359)跌4.4% 近日遭摩根大通减持64.02万股H股
金吾财讯 · 05-03 10:31
【港股通】药明康德(02359)跌4.4% 近日遭摩根大通减持64.02万股H股
药明康德盘中异动 快速下跌5.05%
自选股智能写手 · 05-03 10:25
药明康德盘中异动 快速下跌5.05%
药明康德(02359)股价下跌5.045%,现价港币$36.7
阿斯达克财经 · 05-03 10:25
药明康德(02359)股价下跌5.045%,现价港币$36.7
智通AH统计|5月2日
智通财经 · 05-02 16:15
智通AH统计|5月2日
药明康德(02359)上涨10.01%,报39.0元/股
金融界 · 05-02 14:03
药明康德(02359)上涨10.01%,报39.0元/股
财报季盘点|医药板块TOP1!CXO龙头药明康德斥资近50亿现金分红回购
挖贝网 · 05-02 12:20
财报季盘点|医药板块TOP1!CXO龙头药明康德斥资近50亿现金分红回购
CRO概念股早盘普涨 药明康德涨超6%康龙化成涨超5%
新浪港股 · 05-02
CRO概念股早盘普涨 药明康德涨超6%康龙化成涨超5%
港股异动 | CRO概念股早盘普涨 美联储加息预期逐步减弱 创新药投融资环境有望逐步回暖
智通财经 · 05-02
港股异动 | CRO概念股早盘普涨 美联储加息预期逐步减弱 创新药投融资环境有望逐步回暖
药明康德盘中异动 股价大涨5.08%
自选股智能写手 · 05-02
药明康德盘中异动 股价大涨5.08%
药明康德(02359.HK)4月30日耗资2005万元回购45.73万股A股
港股那点事 · 04-30
药明康德(02359.HK)4月30日耗资2005万元回购45.73万股A股
上市公司董事长年薪PK:药明康德居首,两位“1元”董事长引关注
蓝鲸财经 · 04-30
上市公司董事长年薪PK:药明康德居首,两位“1元”董事长引关注
药明康德(02359)4月30日斥资约2004.64万元回购A股45.73万股
智通财经网 · 04-30
药明康德(02359)4月30日斥资约2004.64万元回购A股45.73万股
药明康德(02359.HK)今回购45.73万A股 涉资逾2,004万人民币
阿斯达克财经 · 04-30
药明康德(02359.HK)今回购45.73万A股 涉资逾2,004万人民币
药明康德(02359)下跌2.07%,报35.55元/股
金融界 · 04-30
药明康德(02359)下跌2.07%,报35.55元/股
《大行》野村:药明康德(02359.HK)首季业绩符预期 维持今年指引
阿斯达克财经 · 04-30
《大行》野村:药明康德(02359.HK)首季业绩符预期 维持今年指引
加载更多
公司概况
公司名称:
药明康德
所属市场:
SEHK
上市日期:
--
主营业务:
无锡药明康德新药开发股份有限公司是一家主要提供新药研发、生产与配套服务以及相关技术平台服务的中国投资控股公司。该公司主要发现、研发及生产小分子药物、细胞疗法及基因疗法,以及提供医疗器械测试服务。该公司主要通过四个业务部门运营,包括中国区实验室服务部门、合约生产组织/合约研发及生产组织服务(CMO/CDMO服务)部门、美国区实验室服务部门以及临床研究服务部门。
发行价格:
--
{"stockData":{"symbol":"02359","market":"HK","secType":"STK","nameCN":"药明康德","latestPrice":36.6,"timestamp":1714723740030,"preClose":38.65,"halted":0,"volume":6641132,"delay":0,"floatShares":387076150,"shares":2933336997,"eps":3.5593996,"marketStatus":"休市中","marketStatusCode":7,"change":-2.05,"latestTime":"05-03 16:09:00","open":38.6,"high":39.1,"low":35.8,"amount":244504676,"amplitude":0.085382,"askPrice":36.65,"askSize":900,"bidPrice":36.6,"bidSize":78600,"shortable":3,"etf":0,"ttmEps":3.463825834950546,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1714959000000},"adr":0,"listingDate":1544630400000,"adjPreClose":38.65,"dividendRate":0.029244,"openAndCloseTimeList":[[1714699800000,1714708800000],[1714712400000,1714723200000]],"volumeRatio":0.8652794380069041,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"603259","market":"SH","secType":"STK","nameCN":"药明康德","latestPrice":43.67,"timestamp":1714460400000,"preClose":44.57,"halted":0,"volume":80698597,"delay":0,"premium":"-23.00"}},"requestUrl":"/m/hq/s/02359/","defaultTab":"news","newsList":[{"id":"2432392854","title":"港股收盘(05.03) | 恒指收涨1.48% 科网股、博彩股再度强势 快狗打车(02246)盘中暴拉1.25倍","url":"https://stock-news.laohu8.com/highlight/detail?id=2432392854","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2432392854?lang=zh_cn&edition=full","pubTime":"2024-05-03 16:39","pubTimestamp":1714725597,"startTime":"0","endTime":"0","summary":"截至收盘,涨5.48%,报127港元,成交额26.89亿港元,贡献恒指18.06点。药明康德2024年一季度实现营业收入79.82亿元,同比减少10.95%;归母净利润19.42亿元,同比减少10.42%。热门异动股1. 快狗打车放量暴涨。大家乐集团日前发布盈喜,预期截至2024年3月31日止财政年度取得股东应占溢利约3.3亿港元,而去年同期股东应占溢利为1.104亿港元。若剔除政府于疫情期间资助则预期增长约3.7倍。截至收盘,涨2.85%,报74港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1117084.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2432944949","title":"港股药明系普跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2432944949","media":"第一财经","top":-1,"share":"https://www.laohu8.com/m/news/2432944949?lang=zh_cn&edition=full","pubTime":"2024-05-03 15:50","pubTimestamp":1714722603,"startTime":"0","endTime":"0","summary":"药明合联跌近11%,药明康德跌超5%,药明生物跌超4%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405031550037925bd46&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405031550037925bd46&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432941019","title":"药明康德港股一度跌超7% 此前招商证券下调其港股评级至持有","url":"https://stock-news.laohu8.com/highlight/detail?id=2432941019","media":"新浪港股","top":-1,"share":"https://www.laohu8.com/m/news/2432941019?lang=zh_cn&edition=full","pubTime":"2024-05-03 15:48","pubTimestamp":1714722480,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n 5月3日,药明康德股票在香港一度下跌7.4%,创下4月5日以来最大盘中跌幅。截至发稿,跌幅收窄至5.6%。消息面上,招商证券此前将该股评级从买进下调为持有。\n\n股市回暖,抄底炒股先开户!智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读,尽在新浪财经APP\n\n责任编辑:常福强","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/jhzx/2024-05-03/doc-inatxumz6379630.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/jhzx/2024-05-03/doc-inatxumz6379630.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2432551948","title":"【券商聚焦】招银国际削药明康德(02359)A股目标价20.9% 惟指其首季业绩在艰难环境下表现平稳","url":"https://stock-news.laohu8.com/highlight/detail?id=2432551948","media":"金吾财讯","top":-1,"share":"https://www.laohu8.com/m/news/2432551948?lang=zh_cn&edition=full","pubTime":"2024-05-03 14:17","pubTimestamp":1714717068,"startTime":"0","endTime":"0","summary":"金吾财讯 | 招银国际发研报指,药明康德 1Q业绩在艰难环境下表现平稳。收入同比下降11.0%至79.8亿元,剔除新冠商业化项目后收入同比下降1.8%,经调整non-IFRS净利润同比下降18.3%至19.1亿元。管理层维持2024年业绩指引,预计收入达到383至405亿元,剔除新冠商业化项目后将增长2.7至8.6%,同时预计non-IFRS净利率将保持与2023年相当的水平。该行维持药明康德买入评级,A股目标价由67.3元人民币下调至53.23元人民币。","market":"us","thumbnail":"https://static.szfiu.com/news/20200915/MGYzMDMzNGFiY2IxZDI0MzU2YTQ4NTEzZTUyODAwMDc0ODA2MTY2.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20200915/MGYzMDMzNGFiY2IxZDI0MzU2YTQ4NTEzZTUyODAwMDc0ODA2MTY2.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1936241","is_publish_highlight":false,"gpt_icon":0},{"id":"2432181529","title":"港股异动 | CRO概念股全线回落 药明康德(02359)跌超7%领跌 公司首季利润率不及预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2432181529","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2432181529?lang=zh_cn&edition=full","pubTime":"2024-05-03 11:26","pubTimestamp":1714706785,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,CRO概念股全线回落,截至发稿,药明康德跌6.47%,报36.15元;凯莱英跌5.33%,报63.05元;康龙化成跌4.96%,报9.96港元;泰格医药跌3.23%,报34.5港元。消息面上,药明康德2024年一季度实现营业收入79.82亿元,同比减少10.95%;归母净利润19.42亿元,同比减少10.42%。浦银国际指出,药明康德1Q24经调整Non-IFRS归母净利润低于预期。公司早期业务受行业融资疲软影响,考虑到降息预期已进一步推迟至2024年底,该行对早期业务收入增速持较为保守态度。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1117040.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2432166994","title":"【港股通】药明康德(02359)跌4.4% 近日遭摩根大通减持64.02万股H股","url":"https://stock-news.laohu8.com/highlight/detail?id=2432166994","media":"金吾财讯","top":-1,"share":"https://www.laohu8.com/m/news/2432166994?lang=zh_cn&edition=full","pubTime":"2024-05-03 10:31","pubTimestamp":1714703485,"startTime":"0","endTime":"0","summary":"金吾财讯 | 药明康德(02359)股价表现疲软,截至发稿,报36.95港元,跌4.4%,成交额8131.2万港元。消息面上,根据香港联交所5月2日披露的文件,摩根大通(JPMorgan Chase & Co.)于4月26日以场内每股均价34.9789港元,场外每股均价34.9502港元合计售出药明康德64.02万股H股股份,价值约2,239.49万港元。售出后,摩根大通最新持股数目为3,427.8万股股份,好仓比例由9.02%降至8.85%。","market":"hk","thumbnail":"https://static.szfiu.com/news/20210810/ZTU4MTQyOTUwMTU0Mjk=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/ZTU4MTQyOTUwMTU0Mjk=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1936217","is_publish_highlight":false,"gpt_icon":0},{"id":"2432994803","title":"药明康德盘中异动 快速下跌5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432994803","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432994803?lang=zh_cn&edition=full","pubTime":"2024-05-03 10:25","pubTimestamp":1714703114,"startTime":"0","endTime":"0","summary":"2024年05月03日早盘10时25分,药明康德股票出现异动,股价快速下挫5.05%。药明康德股票所在的生物技术行业中,整体跌幅为0.57%。消息层面,截至10时25分,药明康德股票正面舆情新闻比例8.51%。该行表示,撇除COVID相关收入的影响,药明康德首季收入则同比下跌1.8%,当中美国及欧洲市场收入增长0.4%及3.9%,来自中国市场的收入则跌3.3%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240503102515861eac6c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240503102515861eac6c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432786994","title":"药明康德(02359)股价下跌5.045%,现价港币$36.7","url":"https://stock-news.laohu8.com/highlight/detail?id=2432786994","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2432786994?lang=zh_cn&edition=full","pubTime":"2024-05-03 10:25","pubTimestamp":1714703100,"startTime":"0","endTime":"0","summary":"[下跌股]药明康德(02359) 股价在上午10:25比前收市价下跌5.045%,现股价为港币$36.7。至目前为止,今日最高价为$39.1,而最低价为$36.7。总成交量为208.956万股,总成交金额为港币$7.918千万。","market":"other","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180126135515084_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180126135515084_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD240503989/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2432562854","title":"智通AH统计|5月2日","url":"https://stock-news.laohu8.com/highlight/detail?id=2432562854","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2432562854?lang=zh_cn&edition=full","pubTime":"2024-05-02 16:15","pubTimestamp":1714637705,"startTime":"0","endTime":"0","summary":"智通财经APP数据显示,截止5月2日收盘,东北电气、弘业期货、浙江世宝分列AH溢价率前三位,溢价率分别为988.71%、754.48%、508.17%;招商银行、比亚迪股份、紫金矿业分列AH溢价率末三位,溢价率分别为15.29%、16.32%、21.07%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1116887.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2432764385","title":"药明康德(02359)上涨10.01%,报39.0元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2432764385","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2432764385?lang=zh_cn&edition=full","pubTime":"2024-05-02 14:03","pubTimestamp":1714629804,"startTime":"0","endTime":"0","summary":"5月2日,药明康德盘中上涨10.01%,截至14:03,报39.0元/股,成交1.2亿元。无锡药明康德新药开发股份有限公司是一家全球领先的一体化新药研发和生产服务提供商,主要通过其“CRDMO”和“CTDMO”业务模式,为全球生物医药行业提供包括化学药研发和生产、生物学研究、临床前测试和临床试验研究、细胞及基因疗法研发、测试和生产等在内的全方位服务。截至2024年一季报,药明康德营业总收入79.82亿元、净利润19.42亿元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/05/02140340509713.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2432169546","title":"财报季盘点|医药板块TOP1!CXO龙头药明康德斥资近50亿现金分红回购","url":"https://stock-news.laohu8.com/highlight/detail?id=2432169546","media":"挖贝网","top":-1,"share":"https://www.laohu8.com/m/news/2432169546?lang=zh_cn&edition=full","pubTime":"2024-05-02 12:20","pubTimestamp":1714623642,"startTime":"0","endTime":"0","summary":"药明康德不仅业绩增长稳健,更通过高达28.82亿元的现金分红,让股东们共享了公司发展的成果。药明康德的这一分红举措,是对其持续增长的业绩的直接回馈。药明康德在2023年的营收和净利润均创下历史新高,这一成绩的取得,离不开股东们长期以来的信任与支持。因此,药明康德通过现金分红的方式,将公司的成长红利回馈给股东,这不仅是对股东的一种回报,也是其社会责任的体现。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050212234587c9b259&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050212234587c9b259&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432618955","title":"CRO概念股早盘普涨 药明康德涨超6%康龙化成涨超5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432618955","media":"新浪港股","top":-1,"share":"https://www.laohu8.com/m/news/2432618955?lang=zh_cn&edition=full","pubTime":"2024-05-02 11:34","pubTimestamp":1714620872,"startTime":"0","endTime":"0","summary":"CRO概念股早盘普涨,药明康德(02359)上涨6.49%,报37.75港元;康龙化成(03759)上涨5.25%,报10.22港元;药明生物(02269)上涨5.24%,报14.46港元;金斯瑞生物科技(01548)上涨3.44%,报12.04港元。\n\n股市回暖,抄底炒股先开户!智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-05-02/doc-inatvexf7589255.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-05-02/doc-inatvexf7589255.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2432974616","title":"港股异动 | CRO概念股早盘普涨 美联储加息预期逐步减弱 创新药投融资环境有望逐步回暖","url":"https://stock-news.laohu8.com/highlight/detail?id=2432974616","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2432974616?lang=zh_cn&edition=full","pubTime":"2024-05-02 11:12","pubTimestamp":1714619577,"startTime":"0","endTime":"0","summary":"消息面上,美联储5月会议维持利率不变,鲍威尔也否定了加息选项,同时宣布缩表即将减速。湘财证券指出,虽然当前CXO受国内外医药投融资下滑影响业绩承压,但鉴于美联储加息预期逐步减弱,以及经过近两年全球biotech领域估值泡沫的出清,全球生技产业性价比已凸显,创新药投融资环境有望逐步回暖,看好CXO长期向好的短期改善。“生物制造”已经被写入2024年政府工作报告并被列为新增长引擎之一。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1116838.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2432692401","title":"药明康德盘中异动 股价大涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432692401","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432692401?lang=zh_cn&edition=full","pubTime":"2024-05-02 10:58","pubTimestamp":1714618685,"startTime":"0","endTime":"0","summary":"2024年05月02日早盘10时58分,药明康德股票出现异动,股价急速上涨5.08%。药明康德股票所在的生物技术行业中,整体涨幅为0.75%。消息层面,截至10时58分,药明康德股票正面舆情新闻比例2%。该行表示,撇除COVID相关收入的影响,药明康德首季收入则同比下跌1.8%,当中美国及欧洲市场收入增长0.4%及3.9%,来自中国市场的收入则跌3.3%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405021058067a57e595&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405021058067a57e595&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431983396","title":"药明康德(02359.HK)4月30日耗资2005万元回购45.73万股A股","url":"https://stock-news.laohu8.com/highlight/detail?id=2431983396","media":"港股那点事","top":-1,"share":"https://www.laohu8.com/m/news/2431983396?lang=zh_cn&edition=full","pubTime":"2024-04-30 16:59","pubTimestamp":1714467597,"startTime":"0","endTime":"0","summary":"格隆汇4月30日丨药明康德(02359.HK)发布公告,2024年4月30日耗资2005万元人民币回购45.73万股A股,每股回购价格43.57-44.7元。\n\n股市回暖,抄底炒股先开户!智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-04-30/doc-inatrchv2210939.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-04-30/doc-inatrchv2210939.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2431395983","title":"上市公司董事长年薪PK:药明康德居首,两位“1元”董事长引关注","url":"https://stock-news.laohu8.com/highlight/detail?id=2431395983","media":"蓝鲸财经","top":-1,"share":"https://www.laohu8.com/m/news/2431395983?lang=zh_cn&edition=full","pubTime":"2024-04-30 16:54","pubTimestamp":1714467286,"startTime":"0","endTime":"0","summary":"赶在“五一”小长假前一天,A股上市公司2023年业绩报告披露完毕。作为各大上市公司的掌门人,董事长们的薪酬情况也随之曝光。iFinD数据显示,共有15家上市公司的董事长年薪超千万,最高达到4196.86万元;董事长年薪超过百万的上市公司超过2000家;同时还有60余家公司的董事长年薪不足10万,此外还有多家公司的董事长年薪为0。根据披露,药明康德2023年实现营收约403.41亿元,同比增长2.51%;归母净利润为96.07亿元,同比增长9%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/231343","is_publish_highlight":false,"gpt_icon":0},{"id":"2431439396","title":"药明康德(02359)4月30日斥资约2004.64万元回购A股45.73万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2431439396","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2431439396?lang=zh_cn&edition=full","pubTime":"2024-04-30 16:54","pubTimestamp":1714467255,"startTime":"0","endTime":"0","summary":"智通财经APP讯,药明康德(02359)发布公告,于2024年4月30日斥资约2004.64万元(人民币,下同)回购A股股份45.73万股,每股回购价格为43.57-44.7元。更多港股重磅资讯,下载智通财经app更多港股及海外理财资讯,请点击www.zhitongcaijing.com(搜索“智通财经”);欲加入智通港股投资群,请加智通客服微信(ztcjkf)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1116245.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2431396331","title":"药明康德(02359.HK)今回购45.73万A股 涉资逾2,004万人民币","url":"https://stock-news.laohu8.com/highlight/detail?id=2431396331","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2431396331?lang=zh_cn&edition=full","pubTime":"2024-04-30 16:53","pubTimestamp":1714467180,"startTime":"0","endTime":"0","summary":"药明康德(02359.HK) 公布,今日(30日)于上交所回购45.73万股,每股作价介乎43.57元人民币(下同)至44.7元,涉资共2,004.64万元。(js/u)(港股报价延迟最少十五分钟。沽空资料截至 2024-04-30 16:25。)AASTOCKS新闻","market":"fut","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20181129150541971_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20181129150541971_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/analysis/china-hot-topic-content.aspx?id=NOW.1346518&catg=4&source=AAFN","is_publish_highlight":false,"gpt_icon":0},{"id":"2431629783","title":"药明康德(02359)下跌2.07%,报35.55元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2431629783","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2431629783?lang=zh_cn&edition=full","pubTime":"2024-04-30 15:57","pubTimestamp":1714463824,"startTime":"0","endTime":"0","summary":"4月30日,药明康德盘中下跌2.07%,截至15:57,报35.55元/股,成交3.05亿元。至2022年,公司已与全球30多个国家的6000多家合作伙伴开展研发创新项目,被MSCI评为ESGAA级,致力于实现“让天下没有难做的药,难治的病”的愿景。截至2024年一季报,药明康德营业总收入79.82亿元、净利润19.42亿元。4月29日,公司以每股42.95-45.01人民币回购45.21万股,回购金额2005万人民币。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/04/30155740493474.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2431036714","title":"《大行》野村:药明康德(02359.HK)首季业绩符预期 维持今年指引","url":"https://stock-news.laohu8.com/highlight/detail?id=2431036714","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2431036714?lang=zh_cn&edition=full","pubTime":"2024-04-30 15:46","pubTimestamp":1714463160,"startTime":"0","endTime":"0","summary":"野村发表研报指,药明康德(02359.HK) 今年首季业绩表现符合预期,收入按年跌11%,盈利按年跌10%。由于销售开支比率提升0.3个百分点至2.2%,拖累期内经营溢利率下降2.1个百分点至24%,毛利率亦收窄至37.3%。管理层仍维持2024年业绩指引不变,野村目前对药明康德的投资评级为“买入”,目标价54.56元。(gc/u)(港股报价延迟最少十五分钟。沽空资料截至 2024-04-30 12:25。)AASTOCKS新闻","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180205150919126_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180205150919126_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1346484/latest-news/AAFN","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.wuxiapptec.com.cn","stockEarnings":[{"period":"1week","weight":0.0398},{"period":"1month","weight":-0.0161},{"period":"3month","weight":-0.1625},{"period":"6month","weight":-0.6153},{"period":"1year","weight":-0.4717},{"period":"ytd","weight":-0.5393}],"compareEarnings":[{"period":"1week","weight":0.0467},{"period":"1month","weight":0.1047},{"period":"3month","weight":0.1894},{"period":"6month","weight":0.046},{"period":"1year","weight":-0.0738},{"period":"ytd","weight":0.0838}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"无锡药明康德新药开发股份有限公司是一家主要提供新药研发、生产与配套服务以及相关技术平台服务的中国投资控股公司。该公司主要发现、研发及生产小分子药物、细胞疗法及基因疗法,以及提供医疗器械测试服务。该公司主要通过四个业务部门运营,包括中国区实验室服务部门、合约生产组织/合约研发及生产组织服务(CMO/CDMO服务)部门、美国区实验室服务部门以及临床研究服务部门。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.018355},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.020248},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.039874},{"month":4,"riseRate":0.5,"avgChangeRate":0.004228},{"month":5,"riseRate":0.5,"avgChangeRate":-0.017329},{"month":6,"riseRate":0.8,"avgChangeRate":0.101299},{"month":7,"riseRate":0.6,"avgChangeRate":0.050449},{"month":8,"riseRate":0.4,"avgChangeRate":0.041019},{"month":9,"riseRate":0.4,"avgChangeRate":-0.015832},{"month":10,"riseRate":0.6,"avgChangeRate":0.02437},{"month":11,"riseRate":0.4,"avgChangeRate":0.027502},{"month":12,"riseRate":0.6,"avgChangeRate":0.018311}],"exchange":"SEHK","name":"药明康德","nameEN":"WUXI APPTEC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"药明康德(02359)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供药明康德(02359)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"药明康德,02359,药明康德股票,药明康德股票老虎,药明康德股票老虎国际,药明康德行情,药明康德股票行情,药明康德股价,药明康德股市,药明康德股票价格,药明康德股票交易,药明康德股票购买,药明康德股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"药明康德(02359)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供药明康德(02359)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}